Non-cirrhotic portal fibrosis related end stage liver disease in adults: Evaluation from a study on living donor liver transplant recipients

Hepatology International

Volumn 5, Issue 4, 2011, Pages 882-889

  Saigal, Sanjiv ^a   Nayak, Nabeen C ^a   Jain, Deepali ^a   Kumaran, Vinay ^a   Mohanka, Ravi ^a   Saraf, Neeraj ^a   Rastogi, Amit ^a   Mehta, Naimesh ^a   Nundy, Samiran ^a   Soin, Arvinder ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

End stage liver disease; Liver transplant; Non cirrhotic; Portal fibrosis

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ARTICLE; BODY MASS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; END STAGE LIVER DISEASE; EXPLANT; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL;

EID: 81855185322     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9246-7     Document Type: Article

References (30)

1. Ramalingaswami V, Wig KL, Sama SK. Cirrhosis of the liver in northern India. A clinicopathological study. Arch Intern Med 1962;110:350-358
2. Basu AK, Boyer J, Bhattacharya R, Mallik KC, Sen Gupta KP. Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I Clinical and function studies and results of operation. Indian J Med Res 1967;55:336-350
3. Boyer JL, Sen Gupta KP, Biswas SK, Pal NC, Basu Mallick KC, Iber FL, Basu AK. Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extra hepatic portal vein obstruction. Ann Intern Med 1967;66:41-68
4. Mikkelsen WP, Edmondson HA, Peters RL, Redeker AG, Reynolds TB. Extra- and intrahepatic-portal hypertension without cirrhosis (hepartoportal sclerosis). Ann Surg 1965;162:602-620
5. Nayak NC, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol 1969;87:359-369
6. Iber FL. Editorial Note: obliterative portal venopathy of the liver and "Idiopathic portal hypertension". Ann Intern Med 1969;71:660-661
7. Okuda K, Nakashima T, Okudaira M, Kage M, Aida Y, Omata M, Sugiura M, Kameda H, Inokuchi K, Bhusnurmath SR, Aikat BA. Liver pathology of idiopathic portal hypertension. Comparison with noncirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver 1982;2:176-192 (Pubitemid 13249218)
8. Okudaira K, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis. 2002;22:059-072
9. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: Current concepts and management. J Gastroenterol Hepatol 2002;17:526-534 (Pubitemid 34748172)
10. Dhiman RK, Chawla YK, Vashista RK. Non-cirrhotic portal fibrosis. In Helmy A, editor. Portal Hypertension: Pathogenesis and Management. Newyork: Nova Scientific Publishers;2006. 339-364
11. Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, Lesmana LA, Guha Mazumder D, Omata M, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Sharma P, Shiha G, Sollano J; Members of the APASL working party on portal hypertension. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hep Intl 2007;1:398-413
12. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005;11:627-634 (Pubitemid 40872900)
13. Isabel Fiel M, Thung SN, Hytiroglou P, Emre S, Schiano TD. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol 2007;31:607-614 (Pubitemid 46569046)
14. Geramizadeh B, Malek-Hosseini SA, Salahi H, Bahador A, Nikeghbalian S. Liver failure and the need for transplantation in three patients with hepatoportal sclerosis. Transplant Proc 2008;40:3526-3528
15. Nayak NC, Vasdev N, Saigal S, Soin AS. End stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol 2010 Mar;41(3):425-430
16. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978 May;31(5):395-414 (Pubitemid 8333033)
17. Sama SK, Bhargava S, Nath NG, Talwar JR, Nayak NC, Tandon BN, Wig KL. Noncirrhotic portal fibrosis. Am J Med 1971 Aug;51(2):160-169
18. Aikat BK, Bhusnurmath SR, Chhuttani PN, Mitra SK, Dutta DV. The pathology of noncirrhotic portal fibrosis: a review of 32 autopsy cases. Hum Pathol 1979 Jul;10(4):405-418 (Pubitemid 9209184)
19. Arora R, Mohanty M, Nundy S, Nayak NC. Phlebothrombosis as a common pathogenic denominator in noncirrhotic portal fibrosis and extrahepatic portal splenic venous obstruction. Indian J Med Res 1984 Mar;79:392-403
20. Loinaz C, Colina F, Musella M, Lopez-Rios F, Gomez R, Jimenez C, Gonzalez Pinto I, Garcia I, Moreno Gonzalez E. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepatogastroenterology 1998;45:1787-1794 (Pubitemid 28515203)
21. Radomski JS, Chojnacki KA, Moritz MJ, Rubin R, Armenti VT, Wilson GA, Herrine S, Conn M. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000;66:1067-1070
22. Dumortier J, Bizollon T, Scoazec JY, Chevallier M, Bancel B, Berger F, Ducerf C, Claudel-Bonvoisin S, Paliard P, Boillot O, Trepo C. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol 2001;36:417-422 (Pubitemid 32250739)
23. Okuda K. Non-cirrhotic portal hypertension: Why is it so common in India? J Gastroenterol Hepatol 2002 Jan;17(1):1-5 (Pubitemid 34304380)
24. Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996;28:195-204 (Pubitemid 26091910)
25. Ibarrola C, Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003;42:251-264 (Pubitemid 36356858)
26. Maheshwari A, Thuluvath PJ. Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol 2006;101:664-668 (Pubitemid 43340946)
27. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 2002;33:1098-1104 (Pubitemid 35416707)
28. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(Suppl 1):S99-S112
29. Sanjeevi A, Lyden E, SundermanB, Weseman R, Ashwathnarayan R, Mukherjee S. Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients. Transplant Proc 2003;35:2977-2980 (Pubitemid 38102106)
30. Newsome PN. Recurrence of nonalcoholic fatty liver disease after liver transplantation: it is common, but does it affect outcome? Liver Transpl 2010 Apr;16(4):420-422